Advanced Medical Equipment & Technology

Boston Scientific Corporation announces primary endpoint results of NECTAR-HF clinical trial

Boston Scientific Corporation:Says that it has released the primary endpoint results from its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical trial.Says the study evaluated 96 New York Heart Association (NYHA) Class II-III patients with heart failure and an ejection fraction of less...

Saturday, 30 Aug 2014 12:39pm EDT

Biosign Technologies Inc sells 12.5 pct of MECK Medical GmbH to raise additional funds

Biosign Technologies Inc:Announced completion of share purchase agreement with 3282909 Nova Scotia Ltd.Agreement under which it has sold 12.5 pct of its 51 pct ownership stake of issued and outstanding shares of MECK Medical GmbH previously acquired on June 30, 2014.

Thursday, 28 Aug 2014 07:03pm EDT

Veeva Systems Inc gives Q3 2015 guidance above analysts' estimates; raises FY 2015 guidance

Veeva Systems Inc:Expects Q3 2015 total revenues between $78 and $79 million.Expects Q3 2015 Non-GAAP operating income between $19 and $20 million.Expects Q3 2015 Non-GAAP fully diluted net income per share of $0.08.Expects FY 2015 total revenues between $300 and $303 million, versus prior guidance...

Thursday, 28 Aug 2014 04:02pm EDT

El En SpA confirms FY 2014 guidance

El En SpA:Says the positive outcome of the first six months allows to confirm the FY 2014 annual ordinary growth and profitability guidance, which is 5 pct revenue growth with an improvement on 2013’s EBIT.Says the net effect of the one time deals closed in the semester will contribute to the...

Thursday, 28 Aug 2014 10:22am EDT

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.